Show simple item record

dc.contributor.authorIrshad, M
dc.contributor.authorGandhi, BM
dc.contributor.authorAcharya, KS
dc.contributor.authorJoshi, YK
dc.contributor.authorTandon, BN
dc.date.accessioned2013-07-05T07:16:02Z
dc.date.available2013-07-05T07:16:02Z
dc.date.issued1990
dc.identifier.citationKIRTDA, DRACHARYAS. 1990. Irshad M, Gandhi BM, Acharya SK, Joshi YK, Tandon BN.Significance of anti-pre-S antibodies in patients with fulminant hepatic failure.Gastroenterol Jpn. 1990 Aug;25(4):499-502..en
dc.identifier.urihttp://profiles.uonbi.ac.ke/sacharya/publications/irshad-m-gandhi-bm-acharya-sk-joshi-yk-tandon-bnsignificance-anti-pre-s-antibo
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/45642
dc.description.abstractAnti-pre-S antibody was tested in 38 sera from patients with fulminant hepatitis (positive for HBsAg and/or IgM anti-HBc) using a specific solid phase enzyme linked immunosorbent assay (ELISA). Anti-pre-S activity was detected in 50 percent sera samples positive for HBsAg but negative for IgM anti-HBc. There were 12.5% sera positive for both HBsAg as well as IgM anti-HBc and 75% sera negative for HBsAg but positive for IgM anti-HBc. The prevalence of HBV-specific DNA-polymerase activity was high in all the three groups whereas anti-HBs positivity was low. Anti-pre-S activity was observed both in the presence as well as in the absence of DNA-polymerase activity. High-anti-pre-S level in fulminant hepatitis B patients was assumed to be implicated in the fast clearance of HBsAg from circulation.en
dc.language.isoenen
dc.titleSignificance of anti-pre-S antibodies in patients with fulminant hepatic failureen
dc.typeArticleen
local.publisherDepartment of Medicine, College of Health Sciences, University of Nairobien


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record